ABFM Family Medicine Certification Exam
2026/2027 Practice Questions & Answers
with Rationales | Complete Board Review
Study Guide for Clinical Exam Prep
ABFM FAMILY MEDICINE CERTIFICATION EXAM 2026/2027 PRACTICE QUESTIONS &
ANSWERS WITH EXPERT RATIONALE Complete Board Review Study Guide for
Clinical Exam Prep
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
OVERVIEW:
• This comprehensive -question practice bank simulates the ABFM certification
exam format with evidence-based clinical scenarios covering all major domains of
family medicine practice including internal medicine, pediatrics, OB/GYN,
emergency care, chronic disease management, and preventive medicine.
• Study this material by working through questions systematically, reviewing
EXPERT RATIONALE thoroughly for both correct and incorrect options to identify
knowledge gaps, and repeating weak areas before your certification exam attempt.
SECTION 1: CARDIOVASCULAR DISEASE & HYPERTENSION
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
1. A 58-year-old man with a 15-year history of hypertension presents for
routine follow-up. Current blood pressure is 148/92 mmHg on lisinopril 10 mg
daily and chlorthalidone 25 mg daily. He has no symptoms and denies
medication side effects. His creatinine is 1.2 mg/dL with an eGFR of 62
mL/min/1.73m². What is the most appropriate next step in management?
A) Add amlodipine 5 mg daily
B) Increase lisinopril to 20 mg daily
C) Switch chlorthalidone to hydrochlorothiazide 25 mg
D) Add doxazosin 2 mg daily
E) Recheck blood pressure in 1 month without medication changes
✓ B) Increase lisinopril to 20 mg daily
,EXPERT RATIONALE: This patient has resistant hypertension that is not at goal
(target <130/80 mmHg per ACC/AHA guidelines). He is on appropriate dual therapy
with an ACE inhibitor and thiazide diuretic. The next step in optimizing therapy is to
maximize the dose of the ACE inhibitor before adding additional agents. Increasing
lisinopril from 10 mg to 20 mg (maximum dose) is the most appropriate next step.
The patient's renal function is adequate for ACE inhibitor dosing adjustments.
Adding amlodipine would be premature without maximizing current agents first.
Switching to hydrochlorothiazide would be a step backward as chlorthalidone is
more potent. Doxazosin is rarely used for hypertension management in modern
practice.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━
2. A 65-year-old woman presents with chest discomfort described as pressure
in her chest with radiation to her left arm, associated with dyspnea. Her vital
signs show BP 160/95 mmHg, HR 102 bpm, RR 20. EKG shows 2 mm ST
elevation in leads II, III, and aVF. What is the most appropriate immediate
management?
A) Aspirin 325 mg and transfer to nearest PCI-capable facility
B) Nitroglycerin sublingual and observe for 30 minutes
C) Morphine 4 mg IV and beta-blocker
D) Heparin bolus and call cardiology for elective catheterization
E) Troponin level and chest X-ray before making treatment decisions
✓ A) Aspirin 325 mg and transfer to nearest PCI-capable facility
EXPERT RATIONALE: This patient presents with acute STEMI (ST elevation
myocardial infarction) evidenced by inferior wall ST elevations. Immediate
management includes dual antiplatelet therapy (aspirin plus P2Y12 inhibitor) and
emergent transfer to a PCI-capable facility for primary percutaneous coronary
intervention. Time is myocardium - every minute of delay increases mortality. While
nitroglycerin, morphine, and beta-blockers are supportive measures, the definitive
,treatment is reperfusion via PCI. Waiting for troponin levels or considering elective
catheterization delays critical reperfusion therapy. Heparin alone is inadequate
without revascularization.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━
3. A 52-year-old man with hyperlipidemia and no prior cardiac events is found
to have an LDL cholesterol of 165 mg/dL on a lipid panel. He is not currently
on any lipid-lowering therapy. According to current ACC/AHA guidelines, what
is the appropriate treatment recommendation?
A) No treatment needed; recheck in 6 months
B) Start moderate-intensity statin therapy
C) Start high-intensity statin therapy
D) Start ezetimibe monotherapy
E) Refer to cardiology before initiating therapy
✓ C) Start high-intensity statin therapy
EXPERT RATIONALE: According to 2018 ACC/AHA guidelines, this patient is in the
high-intensity category due to his age (40-75 years) and presence of a major risk
factor (hyperlipidemia). High-intensity statin therapy (atorvastatin 40-80 mg or
rosuvastatin 20-40 mg) is indicated to achieve an LDL goal of <70 mg/dL in this
population. Moderate-intensity therapy would be insufficient. Ezetimibe
monotherapy lacks the robust cardiovascular benefits of statins. Referral to
cardiology is not necessary for primary lipid management in uncomplicated cases.
This patient clearly needs treatment based on current guidelines.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━
4. A 72-year-old woman with atrial fibrillation presents with acute onset
dyspnea and orthopnea. Her heart rate is 145 bpm, blood pressure is 160/98
mmHg, and she has crackles throughout both lung fields. Chest X-ray
, confirms pulmonary edema. She is on warfarin for stroke prevention. What is
the most appropriate initial management?
A) Digoxin 0.5 mg IV as loading dose
B) IV furosemide, oxygen, and IV diltiazem for rate control
C) Immediate cardioversion
D) Dobutamine infusion
E) Increase warfarin dose for better anticoagulation
✓ B) IV furosemide, oxygen, and IV diltiazem for rate control
EXPERT RATIONALE: This patient has acute decompensated heart failure with
rapid atrial fibrillation. Initial management focuses on: 1) treating pulmonary
edema with IV diuretics and oxygen, 2) controlling the rapid ventricular rate with IV
rate-control agents (diltiazem, verapamil, or beta-blockers), and 3) maintaining
anticoagulation. Diltiazem is appropriate for acute rate control in this setting.
Digoxin has a slow onset and is no longer first-line. Cardioversion is reserved for
hemodynamically unstable patients or those with WPW. Dobutamine would worsen
the clinical picture by increasing heart rate and afterload. Warfarin adjustment is
unnecessary and unrelated to acute management.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━
5. A 45-year-old man presents with sudden onset chest pain radiating to his
back. His blood pressure is 185/110 mmHg with a difference of 25 mmHg
between his right and left arms. A chest X-ray shows a widened mediastinum.
What is the most likely diagnosis?
A) Acute myocardial infarction
B) Aortic dissection
C) Pulmonary embolism
D) Tension pneumothorax
2026/2027 Practice Questions & Answers
with Rationales | Complete Board Review
Study Guide for Clinical Exam Prep
ABFM FAMILY MEDICINE CERTIFICATION EXAM 2026/2027 PRACTICE QUESTIONS &
ANSWERS WITH EXPERT RATIONALE Complete Board Review Study Guide for
Clinical Exam Prep
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
OVERVIEW:
• This comprehensive -question practice bank simulates the ABFM certification
exam format with evidence-based clinical scenarios covering all major domains of
family medicine practice including internal medicine, pediatrics, OB/GYN,
emergency care, chronic disease management, and preventive medicine.
• Study this material by working through questions systematically, reviewing
EXPERT RATIONALE thoroughly for both correct and incorrect options to identify
knowledge gaps, and repeating weak areas before your certification exam attempt.
SECTION 1: CARDIOVASCULAR DISEASE & HYPERTENSION
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
1. A 58-year-old man with a 15-year history of hypertension presents for
routine follow-up. Current blood pressure is 148/92 mmHg on lisinopril 10 mg
daily and chlorthalidone 25 mg daily. He has no symptoms and denies
medication side effects. His creatinine is 1.2 mg/dL with an eGFR of 62
mL/min/1.73m². What is the most appropriate next step in management?
A) Add amlodipine 5 mg daily
B) Increase lisinopril to 20 mg daily
C) Switch chlorthalidone to hydrochlorothiazide 25 mg
D) Add doxazosin 2 mg daily
E) Recheck blood pressure in 1 month without medication changes
✓ B) Increase lisinopril to 20 mg daily
,EXPERT RATIONALE: This patient has resistant hypertension that is not at goal
(target <130/80 mmHg per ACC/AHA guidelines). He is on appropriate dual therapy
with an ACE inhibitor and thiazide diuretic. The next step in optimizing therapy is to
maximize the dose of the ACE inhibitor before adding additional agents. Increasing
lisinopril from 10 mg to 20 mg (maximum dose) is the most appropriate next step.
The patient's renal function is adequate for ACE inhibitor dosing adjustments.
Adding amlodipine would be premature without maximizing current agents first.
Switching to hydrochlorothiazide would be a step backward as chlorthalidone is
more potent. Doxazosin is rarely used for hypertension management in modern
practice.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━
2. A 65-year-old woman presents with chest discomfort described as pressure
in her chest with radiation to her left arm, associated with dyspnea. Her vital
signs show BP 160/95 mmHg, HR 102 bpm, RR 20. EKG shows 2 mm ST
elevation in leads II, III, and aVF. What is the most appropriate immediate
management?
A) Aspirin 325 mg and transfer to nearest PCI-capable facility
B) Nitroglycerin sublingual and observe for 30 minutes
C) Morphine 4 mg IV and beta-blocker
D) Heparin bolus and call cardiology for elective catheterization
E) Troponin level and chest X-ray before making treatment decisions
✓ A) Aspirin 325 mg and transfer to nearest PCI-capable facility
EXPERT RATIONALE: This patient presents with acute STEMI (ST elevation
myocardial infarction) evidenced by inferior wall ST elevations. Immediate
management includes dual antiplatelet therapy (aspirin plus P2Y12 inhibitor) and
emergent transfer to a PCI-capable facility for primary percutaneous coronary
intervention. Time is myocardium - every minute of delay increases mortality. While
nitroglycerin, morphine, and beta-blockers are supportive measures, the definitive
,treatment is reperfusion via PCI. Waiting for troponin levels or considering elective
catheterization delays critical reperfusion therapy. Heparin alone is inadequate
without revascularization.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━
3. A 52-year-old man with hyperlipidemia and no prior cardiac events is found
to have an LDL cholesterol of 165 mg/dL on a lipid panel. He is not currently
on any lipid-lowering therapy. According to current ACC/AHA guidelines, what
is the appropriate treatment recommendation?
A) No treatment needed; recheck in 6 months
B) Start moderate-intensity statin therapy
C) Start high-intensity statin therapy
D) Start ezetimibe monotherapy
E) Refer to cardiology before initiating therapy
✓ C) Start high-intensity statin therapy
EXPERT RATIONALE: According to 2018 ACC/AHA guidelines, this patient is in the
high-intensity category due to his age (40-75 years) and presence of a major risk
factor (hyperlipidemia). High-intensity statin therapy (atorvastatin 40-80 mg or
rosuvastatin 20-40 mg) is indicated to achieve an LDL goal of <70 mg/dL in this
population. Moderate-intensity therapy would be insufficient. Ezetimibe
monotherapy lacks the robust cardiovascular benefits of statins. Referral to
cardiology is not necessary for primary lipid management in uncomplicated cases.
This patient clearly needs treatment based on current guidelines.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━
4. A 72-year-old woman with atrial fibrillation presents with acute onset
dyspnea and orthopnea. Her heart rate is 145 bpm, blood pressure is 160/98
mmHg, and she has crackles throughout both lung fields. Chest X-ray
, confirms pulmonary edema. She is on warfarin for stroke prevention. What is
the most appropriate initial management?
A) Digoxin 0.5 mg IV as loading dose
B) IV furosemide, oxygen, and IV diltiazem for rate control
C) Immediate cardioversion
D) Dobutamine infusion
E) Increase warfarin dose for better anticoagulation
✓ B) IV furosemide, oxygen, and IV diltiazem for rate control
EXPERT RATIONALE: This patient has acute decompensated heart failure with
rapid atrial fibrillation. Initial management focuses on: 1) treating pulmonary
edema with IV diuretics and oxygen, 2) controlling the rapid ventricular rate with IV
rate-control agents (diltiazem, verapamil, or beta-blockers), and 3) maintaining
anticoagulation. Diltiazem is appropriate for acute rate control in this setting.
Digoxin has a slow onset and is no longer first-line. Cardioversion is reserved for
hemodynamically unstable patients or those with WPW. Dobutamine would worsen
the clinical picture by increasing heart rate and afterload. Warfarin adjustment is
unnecessary and unrelated to acute management.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━
5. A 45-year-old man presents with sudden onset chest pain radiating to his
back. His blood pressure is 185/110 mmHg with a difference of 25 mmHg
between his right and left arms. A chest X-ray shows a widened mediastinum.
What is the most likely diagnosis?
A) Acute myocardial infarction
B) Aortic dissection
C) Pulmonary embolism
D) Tension pneumothorax
